To assess the mid to long-term safety and efficacy of Prostatic Artery Embolization (PAE) at a single-center, cohort of 1075 patients.

To present the results of the Liquid Embolization of Arterial Hemorrhages in Peripheral Vasculature (LAVA) study evaluating safety and efficacy of Lava Liquid Embolic System (Lava LES), an ethylene vinyl alcohol (EVOH), for peripheral arterial hemorrhage (PAH).

The Abstract is the most commonly read component, is the only part that a potential reviewer sees when invited to review a manuscript, and is eventually published in the public domain in PubMed. The majority of readers only read the abstract, so it must provide a concise summary of everything that is significant and innovative in the manuscript. JVIR abstracts are limited to 250 words and are composed of 4 sections: Purpose, Materials and Methods, Results and Conclusion. The Purpose section is usually one sentence proposing a hypothesis-driven objective. A background section preceding the Purpose statement is not necessary. The Materials and Methods section should describe the study's design, study population and demographics, experiments or procedures, and endpoints. The Results section should be data-dense, and present the main outcomes, including adverse events, with quantitative data and statistical analyses. The Conclusion section is usually a single summary sentence. The content of the abstract is also included in searches, so keywords should also be featured.

To determine the extent that social determinants of health have on uterine artery embolization (UAE) utilization for treatment of symptomatic uterine fibroids.

Transcatheter retrograde testicular vein embolisation for symptomatic varicoceles is well-established but has a documented failure rate. Percutaneous anterograde varicocele embolisation may be a suitable alternative. A retrospective observational, descriptive study of consecutive patients who underwent percutaneous anterograde varicocele embolisation at a single centre was performed. Twenty patients (16 adults, 4 adolescents) underwent unilateral varicocele treatment. Technical success rate was 100%. Mean (SD) fluoroscopy time was 106.5 (24.9) seconds. For patients treated for subfertility, mean (SD) DNA fragmentation index significantly decreased from 29.4 (4.48)% to 22 (2.45)% pre and post procedure. No clinical or radiological evidence of varicocele recurrence was detected at 1- and 2- year follow-up. Four patients (20%) experienced self-limiting pain. No major adverse events occurred. Percutaneous anterograde varicocele embolisation appears to be safe with high technical and clinical success rate. Larger studies are required to further evaluate this. Radiation dose may be lower than with retrograde embolisation.

To evaluate the outcomes of early primary stent placement (within 30 days of liver transplantation) for hepatic artery stenosis (HAS).

To assess the delivery, function, and patency of a new expanded polytetrafluoroethylene encapsulated TIPS stent- graft ("Liverty") in an animal model.

To assess the safety and efficacy of Y90 radiation segmentectomy (RS) for neuroendocrine tumor liver metastases (NELMs).

Hepatocellular carcinoma (HCC) is a leading and increasing contributor to cancer-related death worldwide. Recent advancements in both liver-directed therapies in the form of Y-90 radioembolization (Y-90-RE) and systemic therapy in the form of immune checkpoint inhibitors (ICI) have expanded treatment options for patients with an otherwise poor prognosis. Despite these gains, ICIs and Y-90-RE each have key limitations with low objective response rates and persistent hazard of out-of-field recurrence, respectively, and overall survival remains low. However, each therapy's strength can mitigate the other's weakness, making them ideal partners for combination treatment strategies. This review discusses the scientific and clinical rationale for combining Y-90-RE with ICIs, highlights early clinical trial data on its safety and efficacy, and proposes key issues to be addressed in this emerging field. With optimal strategies, combination therapies can potentially result in durable and curative outcomes in later stage patients rarely achieved just a decade ago.

To evaluate oncological outcomes, abscopal effect, and adverse events of pulsed electrical field (PEF) ablation of tumors in the chest, abdomen, and pelvis.

This study aims to test the hypothesis that Pressure Enabled Drug Delivery (PEDD) with a TriNav device would increase delivery of Embospheres via hepatic artery infusion to liver tumors in an oncopig model when compared to a conventional endhole microcatheter. Embospheres (100-300um in size) were fluorescently labeled and infused into porcine liver tumors using conventional technique (n=8) or by PEDD (n=8). Liver tissue was harvested and we analyzed images with a custom Visiopharm Deep Learning algorithm (Visiopharm A/S) to quantitate signal intensity. PEDD increased Embosphere penetration into the tumor by 227% (p = 0.029) when compared to conventional methodology and improved T/N ratio from 2.7 to 4.2. These data demonstrate improved delivery into tumor tissue using PEDD, along with improved selectivity by minimizing relative off-target deposition.

This systematic review aimed to compare covered stent (CS) and bare metal stent (BMS) in treating aortoiliac occlusive disease (AIOD).